Pharmacy market analysis, salary intelligence, and UK job trends. Data-driven insights from 13,147 pharmacies and 5.3M dispensing records.
A falling share of pharmacy adverts quoting a salary looks like growing secrecy — but the data points to a change in the mix of roles, not employer behaviour.
The 1,882 pharmacy vacancies on the UK's aggregated job feeds are a visible subset of hiring, not the whole of it — three structural channels rarely appear as adverts at all.
On the same NHS Jobs board, an NHS trust vacancy almost always shows a banded salary while a GP practice or primary care network post often says only 'Negotiable' — and the reason is structural.
Almost every pharmacist salary printed in UK job adverts comes from the NHS — so the headline number tells you little about community pay.
Advertised UK pharmacy vacancies eased to 1,821 in early August — the first monthly decline of 2026, led by a drop in NHS Jobs listings.
Two sources carry more than half of the UK's tracked pharmacy vacancies — and the sector's biggest group of employers barely appears online at all.
Advertised UK pharmacy vacancies held roughly flat at 1,919 in late July, as the spring hiring surge levelled off.
The UK's ~1,900 advertised pharmacy vacancies count adverts, not full-time jobs — and where hours are visible, roughly a fifth of the headline is part-time.
A single 200-listing snapshot of the NHS Jobs pharmacy feed contained 149 different employers — and fewer than half were hospital trusts.
The same feed can show a big operator with 70 vacancies one week and a handful the next — here is how to read the numbers without being misled.
PharmSee's analysis of 194 live supermarket pharmacy vacancies finds four operators advertising four very different role mixes — from Tesco's manager-led model to Asda's pharmacist bench.
Newly geocoded vacancy data reveals which regions the major chains are advertising most heavily — and where they are not.
A plain-English guide to Sciensus, HealthNet, Alcura and Lloyds Clinical — the pharmacies that deliver your specialist medicines.
A plain-English read of the Q4 2025/26 emergency-care data and where pharmacy fits into the picture.
A guide to the HST pathway: what it evaluates, what it has approved, and how patients reach these medicines.
Why some expensive medicines are available on the NHS with conditions attached, and what this means at the pharmacy counter.
Every winter surge brings parents of coughing infants to the pharmacy counter — here is what community pharmacy can usefully do, and where referral is non-negotiable.
Creatine, magnesium, omega-3, probiotics and the rest — a single landing page to navigate what the evidence supports and what it doesn't.
How the post-Windsor Framework mechanism keeps UK-licensed medicines flowing to Northern Ireland community pharmacy — and which products sit inside it.
The UK's first routinely commissioned gene-editing therapy is changing lifelong medication regimens — here is what to expect when a patient returns to your counter.
A short guide to the prescriptions, prophylaxis and red flags community pharmacy should expect when a CAR-T patient is discharged into the community.
Pregnancy, heavy menstrual bleeding, coeliac disease and vegetarian diets all drive iron deficiency differently — and community pharmacy choice should reflect that.
Specialist infant formulas on the ACBS list are community-pharmacy-dispensed NHS prescriptions — with indications, pathways and substitution rules of their own.
Gene, cell and tissue-engineered therapies are no longer confined to tertiary centres — community pharmacy teams increasingly see patients on aftercare pathways.
The seven-condition clinical pathway permits supply for some infections but retains referral for others — here's where pharmacists act and where they still send patients on.
The MHRA's April 2026 approval of a single-dose 7.2mg semaglutide pen adds a higher top-dose option for weight management — here's what community pharmacy needs to know.
Three cities within 70 miles of each other — but their pharmacy markets look very different.
PharmSee's analysis of NHSBSA dispensing data reveals that Birmingham's 142 community pharmacies average just £77,966 in annual dispensing revenue — nearly half the figure in Newcastle.
Three neighbouring cities with sharply different pharmacy profiles — from Leicester's high GP ratio to Derby's vacancy desert and Nottingham's revenue compression.
Birmingham has more pharmacies, more GPs, and a higher GP-to-pharmacy ratio — but lower revenue and far fewer vacancies than Manchester.
From £1.29 per dispensed item to £31.82 per New Medicine Service consultation, the NHS fee schedule shapes every aspect of community pharmacy economics.
Thirty miles apart, Sheffield and Leeds present strikingly different pharmacy economics — higher revenue in Sheffield, more diverse hiring in Leeds.
Some independent pharmacies generate three to four times the city average in dispensing revenue. PharmSee's data points to location, services, and GP relationships as the key drivers.
In eight of nine English cities measured, independent pharmacies out-earn chain branches. Nottingham is the exception — and the reasons point to a structurally different market.
With an average dispensing revenue of £160,122 per branch, Newcastle's 44 active independent pharmacies lead all nine cities measured by PharmSee — 63% above the local chain average.
With 142 pharmacies but only 47 vacancies — 64% from NHS Jobs — Birmingham's independent pharmacy sector appears to hire through channels invisible to online job boards.
PharmSee's analysis of dispensing revenue across nine urban centres finds independent pharmacies averaging higher NHSBSA-reported revenue per branch than major chains in most measured markets.
Eight of 26 pharmacies within three miles of Exeter city centre have no dispensing activity in the latest NHSBSA data — the highest rate PharmSee has measured in any English city.
PharmSee's cross-city analysis of dispensing revenue reveals that independent pharmacies consistently generate higher revenue per active branch than major chain operators.
Newcastle records the highest dispensing revenue per active pharmacy branch of any English city PharmSee has measured — despite having one of the lowest GP-to-pharmacy ratios.
The two largest cities in Devon record the highest GP-to-pharmacy ratios of any measured English city, pointing to structural demand in the South West.
From £66,788 per branch in London to £141,431 in Newcastle — dispensing revenue tracks the GP-to-pharmacy ratio, with notable exceptions.
At 1.49 GP practices per pharmacy, Plymouth's community pharmacies handle above-average prescription volume — and earn above-average revenue.
With 292 registered pharmacies and the lowest revenue per branch of any major English city, London's pharmacy market presents a paradox of scale and competition.
With 85 registered pharmacies, 67 GP practices, and a 0.79:1 ratio, Nottingham's pharmacy market is one of the most competitive in England.
Between 16% and 32% of registered pharmacy branches show zero dispensing revenue in NHSBSA data, depending on the city. The gap matters for anyone using branch counts to assess pharmacy access.
From 54% in Exeter to 78% in Sunderland, the proportion of independently owned pharmacies differs dramatically between English cities — with implications for hiring, competition, and market structure.
With 106 pharmacies, 150 GP practices, and the highest GP-to-pharmacy ratio PharmSee has measured in a major English city, Liverpool's pharmacy market has distinctive characteristics.
Similar branch counts, different revenue profiles and distinct chain dynamics make the North West's two largest cities a revealing pharmacy comparison.
All six Rowlands Pharmacy branches within three miles of Oxford city centre record no dispensing activity in the latest NHSBSA data — the most concentrated blank in any city PharmSee has measured.
Cookies on PharmSee
We use strictly-necessary cookies to make this site work. With your consent, we also use Google Analytics (to measure aggregate traffic) and Google AdSense (to fund the site). See our Cookie Policy and Privacy Policy.